| Name | Title | Contact Details |
|---|---|---|
Steve Collins |
Chief Information Officer | Profile |
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Struggling with sleep issues? Try CBN for sleep! Slumber Sleep Aid offers variations of plant-based CBD and CBN products for sleep.
First Service Administrators is a Winter Haven, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Get hassle-free reproductive care for Herpes, BV, Yeast, UTI, Primary Care & Contraception. Same-day prescriptions picked up locally in a few hours or delivered FREE, discreetly packaged, to your home.
The Advisory Board is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.